Long-Term Outcomes of Patients with Pre-Existing Essential Tremor After SARS-CoV-2 Infection DOI Creative Commons

Rachel Pakan,

Roham Hadidchi,

Yousef Al-Ani

и другие.

Diagnostics, Год журнала: 2024, Номер 14(24), С. 2774 - 2774

Опубликована: Дек. 10, 2024

Although COVID-19 has been linked to worse outcomes in patients with neurological disorders, its impact on those essential tremor (ET) remains unclear. To investigate clinical of ET and without three a half years post-pandemic. 1074 were evaluated this retrospective study the Montefiore Health System from January 2016 July 2023. Comparisons between positive SARS-CoV-2 polymerase chain reaction test made. Outcomes included post-index date major adverse cardiovascular events (MACEs), new-onset sleep disturbances, fatigue, dyspnea, first-time fall, anxiety, depression, headache, imbalance, mild cognitive impairment, all-cause mortality, adjusted hazard ratios (aHR) adjusting for covariates calculated. had higher prevalence pre-existing type-2 diabetes, anxiety compared COVID-19. was significantly associated risk MACEs, (aHR = 2.39 [1.49, 3.82]), disturbance, 2.12 [1.44, 3.13]), 1.83 [1.27, 2.65]), 1.98 [1.40, 2.80]), 4.76 [2.24, 10.14]), 3.66 [2.02, 6.64]), 2.38 [1.20, 4.70]). not mortality. In ET, increases several long-term health outcomes, but

Язык: Английский

Long-term outcomes of patients with a pre-existing neurological condition after SARS-CoV-2 infection DOI
Roham Hadidchi,

Yousef Al-Ani,

Solbie Choi

и другие.

Journal of the Neurological Sciences, Год журнала: 2025, Номер unknown, С. 123477 - 123477

Опубликована: Апрель 1, 2025

Язык: Английский

Процитировано

0
Long-Term Outcomes of Patients with Pre-Existing Essential Tremor After SARS-CoV-2 Infection DOI Creative Commons

Rachel Pakan,

Roham Hadidchi,

Yousef Al-Ani

и другие.

Diagnostics, Год журнала: 2024, Номер 14(24), С. 2774 - 2774

Опубликована: Дек. 10, 2024

Although COVID-19 has been linked to worse outcomes in patients with neurological disorders, its impact on those essential tremor (ET) remains unclear. To investigate clinical of ET and without three a half years post-pandemic. 1074 were evaluated this retrospective study the Montefiore Health System from January 2016 July 2023. Comparisons between positive SARS-CoV-2 polymerase chain reaction test made. Outcomes included post-index date major adverse cardiovascular events (MACEs), new-onset sleep disturbances, fatigue, dyspnea, first-time fall, anxiety, depression, headache, imbalance, mild cognitive impairment, all-cause mortality, adjusted hazard ratios (aHR) adjusting for covariates calculated. had higher prevalence pre-existing type-2 diabetes, anxiety compared COVID-19. was significantly associated risk MACEs, (aHR = 2.39 [1.49, 3.82]), disturbance, 2.12 [1.44, 3.13]), 1.83 [1.27, 2.65]), 1.98 [1.40, 2.80]), 4.76 [2.24, 10.14]), 3.66 [2.02, 6.64]), 2.38 [1.20, 4.70]). not mortality. In ET, increases several long-term health outcomes, but

Язык: Английский

Процитировано

1